Atheroprotective lipoprotein effects of a niacin-simvastatin combination compared to low- and high-dose simvastatin monotherapy
- 1 April 2009
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 157 (4) , 687.e1-687.e8
Abstract
No abstract availableKeywords
Funding Information
- Dana Foundation
- University of Pennsylvania
This publication has 45 references indexed in Scilit:
- Extended-Release Niacin Alters the Metabolism of Plasma Apolipoprotein (Apo) A-I and ApoB-Containing LipoproteinsArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Effects of Torcetrapib in Patients at High Risk for Coronary EventsNew England Journal of Medicine, 2007
- Effect of Torcetrapib on Carotid Atherosclerosis in Familial HypercholesterolemiaNew England Journal of Medicine, 2007
- Effect of Torcetrapib on the Progression of Coronary AtherosclerosisNew England Journal of Medicine, 2007
- Value of Low-Density Lipoprotein Particle Number and Size as Predictors of Coronary Artery Disease in Apparently Healthy Men and WomenJACC, 2007
- Relationship between the concentration and antiatherogenic activity of high-density lipoproteinsCurrent Opinion in Lipidology, 2006
- Influence of Extended-Release Nicotinic Acid on Nonesterified Fatty Acid Flux in the Metabolic Syndrome With Atherogenic DyslipidemiaThe American Journal of Cardiology, 2005
- Effects of Prolonged Intensive Lipid-Lowering Therapy on the Characteristics of Carotid Atherosclerotic Plaques In Vivo by MRIArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Treatment of hyperlipidemia with combined niacin–statin regimensThe American Journal of Cardiology, 1998
- Fluvastatin with and without niacin for hypercholesterolemiaThe American Journal of Cardiology, 1994